Radiopharm Theranostics Limited (RDPTF) Gross profit 2023–2025
Radiopharm Theranostics Limited (RDPTF) annual gross profit history from SEC filings — each fiscal year as reported.
$39,276FY2025 · since FY2023: $292,359 → $39,276
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $39,276 | -86.9% |
| FY2024 | $299,228 | +2.3% |
| FY2023 | $292,359 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDPTF financial trends
RDPTF RevenueRDPTF Net incomeRDPTF Net marginRDPTF Gross marginRDPTF Operating incomeRDPTF Operating marginRDPTF Operating cash flowRDPTF Free cash flowRDPTF Capital expendituresRDPTF Return on equityRDPTF Stock buybacksRDPTF Dividends paidRDPTF Total assetsRDPTF Total liabilitiesRDPTF Shareholders’ equityRDPTF overview →